Towse ISPOR Incoming President's Remarks
Adaptive Pathways as Incentives for Innovation
Adrian Towse Presentation - Affordability
ISPOR poster ri lwcp 140515
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Devlin mcda philadelphia ispor 150515
ISPOR poster - direct elicitation 280415
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries
Equity Adjusted QALYs? QALYs and Equity
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
Availability, accessibility and applicability of evidence: Transferability - Data versus pragmatism
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potential for PBRSAs
The economics of medical research: Public/private spillovers and the rate of return
Does society wish to prioritise end-of-life treatments over other types of treatment?
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
Multi-Indication Pricing: Do we want it? Can we operationalize it?
Can we really compare and aggregate PRO data between people and setting?
Is balancing value demonstration for payers and patient interests a feasible notion? A Health System Perspective